1. Advancing Regulatory Science for Public Health. A Framework for FDA’s Regulatory Science Initiative;US Food and Drug Administration,2010
2. Translating new science into the drug review process: the US FDA’s Division of Applied Regulatory Science;Rouse;Ther. Innov. Regul. Sci.,2017
3. Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products;US Food and Drug Administration,2004
4. Innovation or Stagnation: Critical Path Opportunities List;US Food and Drug Administration,2006
5. Advancing Regulatory Science at FDA: A Strategic Plan;US Food and Drug Administration,2011